Stocks
Iovance Biotherapeutics (IOVA) EBITDA margin US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| EBITDA margin, % | ? | -35 949% | -436.2% | |||||
| Changes by years, y/y, % | ||||||||
Iovance Biotherapeutics. EBITDA margin, %
Iovance Biotherapeutics. EBITDA margin, changes, pp
Iovance Biotherapeutics (IOVA) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -22 415% | -22 495% | -15 079% | -292.7% | -152.1% | -436.2% | |
| Changes by years, y/y, % | +45 962pp | +22 263pp | ||||||
| Changes by quarters, q/q, % | +23 839pp | -79pp | +7 416pp | +14 786pp | +141pp | |||
